GO
Loading...

India

More

  • Sept 30- Morningstar downgraded its analyst rating on the Pimco Total Return Fund to "bronze" from "gold," citing uncertainty about outflows and the reshuffling of management responsibilities after the exit of co-founder Bill Gross.

  • Sept 29- Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.

  • Sept 29- Salix Pharmaceuticals Ltd said the U.S. Food and Drug Administration approved an expanded use of its constipation treatment. It will compete with Nektar Therapeutics and AstraZeneca Plc's oral drug Movantik, approved by the FDA earlier this month for the same patient population.

  • Sept 29- Salix Pharmaceuticals Ltd said the U.S. Food and Drug Administration approved an expanded use of its constipation treatment. Salix, which is merging with Cosmo Pharmaceuticals SpA's Irish subsidiary, is in talks with Allergan Inc and Actavis Plc about a potential sale, sources have told Reuters in recent weeks.

  • Sept 29- Catalyst Pharmaceutical Partners Inc said its lead drug was found superior in treating symptoms associated with a rare autoimmune disorder, compared with a placebo.

  • Sept 29- Chinese e-cigarette maker Kimree Inc filed to list its shares in the United States at a time when e-cigarette companies are finding it harder to raise capital amid rising competition and increasing regulatory oversight.

  • Chinese e-cigarette maker Kimree files for U.S. IPO Monday, 29 Sep 2014 | 1:33 PM ET

    Sept 29- Chinese e-cigarette company Kimree Inc filed with U.S. regulators on Monday to raise up to $125 million in an initial public offering of American depositary shares. Citigroup is underwriting the IPO, the Guangdong- based company told the U. S Securities and Exchange Commission in a filing.

  • Sept 29- Toyota Motor Sales U.S.A. Inc, a unit of Toyota Motor Corp, said it would recall about 690,00 Tacoma 4 X4 and Tacoma pre-runner pickup trucks to fix issues with the vehicles' rear suspension system. "The involved vehicles' rear suspension system contains leaf springs that are constructed of either three or four leaves.

  • Sept 29- Biometric security company NXT-ID Inc expects to turn profitable next year, Chief Executive Gino Pereira said, as the company rolls out a $150 digital wallet as an alternative to new payment services such as Apple Pay.

  • Sept 29- Perfume and cosmetics maker Coty Inc said Chief Executive Michele Scannavini had stepped down for personal reasons, sending the company's shares down as much as 3 percent.

  • Sept 29- Struggling apparel retailer American Apparel Inc said it had hired Scott Brubaker, a managing director at turnaround firm Alvarez& Marsal, as interim chief executive, three months after ousting controversial CEO and founder Dov Charney.

  • Coty CEO Michele Scannavini steps down Monday, 29 Sep 2014 | 9:12 AM ET

    The company, whose competitors include Estee Lauder Cos Inc, L'Oreal SA and Elizabeth Arden Inc, named Chairman Bart Becht as interim CEO.

  • Sept 29- American Apparel Inc said it hired Scott Brubaker, a managing director at turnaround firm Alvarez& Marsal, as interim chief executive, three months after ousting its CEO and founder Dov Charney. The company also named Hassan Natha, a former Nike Inc executive, as chief financial officer.

  • Sept 29- Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Seattle Genetics said it expected to submit a marketing application to FDA for the drug's supplemental use in 2015..

  • Macy's to hire 86,000 workers for holiday season Monday, 29 Sep 2014 | 8:42 AM ET

    Sept 29- Department store operator Macy's Inc said it planned to hire about 86,000 workers for the holiday shopping season, up from about 83,000 last year.

  • Sept 29- Tonix Pharmaceuticals Holding Corp said its lead pain drug failed the main goal of a mid-stage study, sending its shares down by nearly half in premarket trading. Tonix said it plans to discuss the trial results and the design for a late-stage trial with the U.S. Food and Drug Administration.

  • Sept 29- Seattle Genetics Inc and Takeda Pharmaceutical Co Ltd said their approved cancer drug was successfully used as a consolidation therapy in a late-stage trial for patients with a type of lymphatic cancer. Consolidation therapy is given to cancer patients who have undergone initial therapy and kills any cancer cells that may be left in the body.

  • Sept 29- Encana Corp, Canada's largest natural gas producer, said it would buy Athlon Energy Inc for $5.93 billion in cash, excluding debt, as it accelerates its plan to focus on more-lucrative oil and natural-gas liquids.

  • Tonix Pharma's pain drug fails mid-stage study Monday, 29 Sep 2014 | 6:48 AM ET

    Sept 29- Tonix Pharmaceuticals Holding Corp said its lead pain drug had failed the main goal of a mid-stage study testing if it reduced pain experienced by patients by the 12th week of the trial. The drug, TNX-102, is being tested to treat fibromyalgia, a chronic syndrome characterized by widespread pain and lack of sleep.

  • Encana to buy Athlon Energy for $5.93 bln Monday, 29 Sep 2014 | 6:17 AM ET

    Sept 29- Encana Corp, Canada's largest natural gas producer, said it would buy Athlon Energy Inc for $5.93 billion in cash, excluding debt. Encana, which is shifting its focus to high-value oil and natural gas liquids, will also assume Athlon's $1.15 billion of senior notes. The deal includes about 140,000 net acres owned by Athlon in the oil-rich Midland Basin.